Joseph Sulovski

Joseph Sulovski has a wealth of experience in the clinical operations field. Joseph began their career in 2004 at Medarex as an Assistant Scientist I. In 2005, they moved to Medarex, Inc. as a CRA I. In 2008, they began working at Abbott as a Global Project Team CRA and also at ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company, as a Clinical Trial Manager and Sr. in-house CRA. In 2013, they became a Clinical Trial Head at Novartis. From 2016 to 2021, they held positions at Chromocell Corporation, first as Assistant Director, Clinical Operations and then as Director of Clinical Operations. Most recently, they have been the Sr. Director of Clinical Operations at Meissa Vaccines since 2021.

Joseph Sulovski graduated from the University of Maryland in 2003 with a Bachelor of Science (B.S.) in Biology.